Healx is an innovative technology company that leverages the power of Artificial Intelligence (AI) to accelerate the discovery and development of treatments for rare diseases. Founded in 2014, the company has been pioneering the next generation of drug discovery. Healx’s unique approach involves using a combination of algorithms to predict and de-risk novel connections in biomedical data, moving promising ones toward the clinic. This enables the development of advanced treatment methods for rare disease remedies. As of 2023, Healx has raised a total funding of $66 million and has 95 employees.